Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.
- www.clinicaltrials.gov. Once you are on the website, type "NCT02112526" into the search box and click "Search".
- www.clinicaltrialsregister.eu. Once you are on the website, click "Home and Search", then type "2014-001341-25" in the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "ACE-LY-002" into the search box and click "Find a Study".
Full Study Title: An Open-label, Phase 1b Study of ACP-196 in Subjects with Relapsed or Refractory de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma
Acerta Pharma Protocol Number: ACE-LY-002
National Clinical Trials Number: NCT02112526
EudraCT Number: 2014-001341-25
Acerta Pharma B.V., a member of the AstraZeneca group of companies, sponsored this study and has its headquarters in Oss, the Netherlands.
Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 â€¢ Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org